2007
DOI: 10.1159/000108099
|View full text |Cite
|
Sign up to set email alerts
|

Mild Cognitive Impairment in General Practice: Age-Specific Prevalence and Correlate Results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)

Abstract: Background: Although mild cognitive impairment (MCI) represents a high-risk factor for developing dementia, little is known about the prevalence of MCI among patients of general practitioners (GPs). Aims: Estimation of age-specific prevalence for original and modified concepts of MCI and their association with sociodemographic, medical and genetic (apoE Ε4 genotype) factors among patients of GPs. Methods: A GP practice sample of 3,327 individuals aged 75+ was assessed by structured clinical interviews. Results… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

12
130
2
9

Year Published

2008
2008
2016
2016

Publication Types

Select...
10

Relationship

5
5

Authors

Journals

citations
Cited by 172 publications
(153 citation statements)
references
References 66 publications
12
130
2
9
Order By: Relevance
“…15 The aim was for each study centre to recruit 20 primary care practices with 25 patients. In each practice 50 randomly selected patients from those eligible were invited to participate in the study.…”
Section: Methodsmentioning
confidence: 99%
“…15 The aim was for each study centre to recruit 20 primary care practices with 25 patients. In each practice 50 randomly selected patients from those eligible were invited to participate in the study.…”
Section: Methodsmentioning
confidence: 99%
“…1,2 Several factors are important for the onset of CI and CD, including female sex and the apolipoprotein Eε4 (apoEε4) genotype. 3,4 Changes in blood pressure (BP) are associated with both CI and CD in older people. 5,6 Hypertension might be implicated in the pathogenesis of poor cognition, 7 and recent studies suggest that hypotension could be a risk factor for CI and CD too.…”
mentioning
confidence: 99%
“…In addition, rs75935628 was also genotyped in the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe) case-control samples. [15][16][17] Furthermore, rs75932628 genotypes were imputed in 3 publicly available GWAS datasets, GlaxoSmithKline (GSK), the Alzheimer's Disease Neuroimaging Initiative (ADNI), and the Translational Genomics Research Institute series 2 (TGEN2), which were not analyzed in the previous studies.…”
mentioning
confidence: 99%